ATE352785T1 - Verfahren zum nachweis von hepatitis c antigenen - Google Patents

Verfahren zum nachweis von hepatitis c antigenen

Info

Publication number
ATE352785T1
ATE352785T1 AT00952184T AT00952184T ATE352785T1 AT E352785 T1 ATE352785 T1 AT E352785T1 AT 00952184 T AT00952184 T AT 00952184T AT 00952184 T AT00952184 T AT 00952184T AT E352785 T1 ATE352785 T1 AT E352785T1
Authority
AT
Austria
Prior art keywords
hepatitis
antigens
detecting hepatitis
virus
detecting
Prior art date
Application number
AT00952184T
Other languages
English (en)
Inventor
David Y Chien
Phillip Arcangel
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE352785T1 publication Critical patent/ATE352785T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00952184T 1999-07-28 2000-07-25 Verfahren zum nachweis von hepatitis c antigenen ATE352785T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14607999P 1999-07-28 1999-07-28

Publications (1)

Publication Number Publication Date
ATE352785T1 true ATE352785T1 (de) 2007-02-15

Family

ID=22515775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952184T ATE352785T1 (de) 1999-07-28 2000-07-25 Verfahren zum nachweis von hepatitis c antigenen

Country Status (10)

Country Link
EP (1) EP1295126B1 (de)
JP (2) JP5498637B2 (de)
AT (1) ATE352785T1 (de)
CA (1) CA2380777C (de)
CY (1) CY1106349T1 (de)
DE (1) DE60033190T2 (de)
DK (1) DK1295126T3 (de)
ES (1) ES2279766T3 (de)
PT (1) PT1295126E (de)
WO (1) WO2001009609A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
EP2970947A4 (de) 2013-03-14 2016-10-12 Abbott Lab Rekombinante hcv-ns3-antigene und mutanten für den verbesserten nachweis von antikörpern
JP6505076B2 (ja) 2013-03-14 2019-04-24 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｈｃｖ抗原−抗体組み合わせアッセイおよびこれに使用するための方法および組成物
CN105378099B (zh) 2013-03-14 2021-05-11 雅培制药有限公司 Hcv核心脂质结合结构域单克隆抗体
WO2018027221A1 (en) * 2016-08-05 2018-02-08 University Of Virginia Patent Foundation Compositions and methods for high-sensitivity immunoassays

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
FR2502154A1 (fr) * 1981-03-30 1982-09-24 Trepo Christian Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
DE69225960T2 (de) * 1991-01-31 1999-01-21 Abbott Laboratories, Abbott Park, Ill. Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen
AU2683792A (en) * 1991-09-16 1993-04-27 Genelabs Technologies, Inc. Peptide based hepatitis c virus immunoassays
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
GB9214877D0 (en) * 1992-07-14 1992-08-26 Smith Meters Ltd Dry gas meter
JPH06327482A (ja) * 1993-05-21 1994-11-29 Imuno Japan:Kk オリゴペプタイド、オリゴヌクレオチドならびにｃ型肝炎ウ イルス関連抗体検出方法
US6747136B2 (en) * 1996-04-19 2004-06-08 Karolinska Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
PT1021719E (pt) * 1997-09-22 2007-03-30 Novartis Vaccines & Diagnostic Método para detecção de anticorpos numa amostra

Also Published As

Publication number Publication date
WO2001009609A3 (en) 2003-01-09
EP1295126A2 (de) 2003-03-26
JP5498637B2 (ja) 2014-05-21
ES2279766T3 (es) 2007-09-01
CY1106349T1 (el) 2011-10-12
DK1295126T3 (da) 2007-04-10
JP2003529744A (ja) 2003-10-07
CA2380777C (en) 2011-01-04
PT1295126E (pt) 2007-03-30
DE60033190D1 (de) 2007-03-15
DE60033190T2 (de) 2007-10-31
EP1295126B1 (de) 2007-01-24
JP2010048830A (ja) 2010-03-04
CA2380777A1 (en) 2001-02-08
WO2001009609A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
EP0914155A4 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
ATE293494T1 (de) Verfahren zum konzentrieren von analyten in proben
ATE185350T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
DE69230146D1 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
DE59007613D1 (de) Verfahren zum Nachweis und zur Bestimmung von Humanserumalbumin in biologischen Flüssigkeiten mit Hilfe fluorogener Cyanin-Farbstoffe.
ATE325203T1 (de) Nachweis und identifikation von bakteriengruppen
DE68923605D1 (de) Immunodiagnostisches Verfahren zum Nachweis und zur Bestimmung von Euterentzündung.
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
DE69114339D1 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu.
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
ATE539350T1 (de) Verfahren zum nachweis oder zum bestimmen von hbv
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
DE69207200D1 (de) IMMUNTEST ZUM GLEICHZEITIGEN NACHWEIS VON HIV-1, HIV-2, HTLV-I und HTLV-II ANTIKÖRPERN
EP0556320A4 (en) Monoclonal antibodies to hepatitis c virus and method for using same
ATE367582T1 (de) Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
ATE174060T1 (de) Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
DE60330877D1 (de) Verfahren zum nachweis und zur quantifizierung von hepatitis-c-virus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1295126

Country of ref document: EP